Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System

K-Number: K222653 · 2022-10-28

Decision Date2022-10-28
Product CodeNJD
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System is a medical device manufactured by Smith+Nephew, Inc.. It received FDA 510(k) clearance on 2022-10-28 under approval number K222653. The device is classified under product code NJD. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System?

JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System is a medical device that received FDA 510(k) clearance on 2022-10-28. It is manufactured by Smith+Nephew, Inc.. The 510(k) number is K222653.

When was JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System approved by the FDA?

JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System received FDA 510(k) clearance on 2022-10-28, under approval number K222653.

What company makes JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System?

JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System is manufactured by Smith+Nephew, Inc..

What is the FDA product code for JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System?

The FDA product code for JOURNEY II UK™ and ENGAGE™ Cementless Partial Knee System is NJD.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: NJD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.